Literature DB >> 25527701

What can crystal structures of aminergic receptors tell us about designing subtype-selective ligands?

Mayako Michino1, Thijs Beuming1, Prashant Donthamsetti1, Amy Hauck Newman1, Jonathan A Javitch1, Lei Shi2.   

Abstract

G protein-coupled receptors (GPCRs) are integral membrane proteins that represent an important class of drug targets. In particular, aminergic GPCRs interact with a significant portion of drugs currently on the market. However, most drugs that target these receptors are associated with undesirable side effects, which are due in part to promiscuous interactions with close homologs of the intended target receptors. Here, based on a systematic analysis of all 37 of the currently available high-resolution crystal structures of aminergic GPCRs, we review structural elements that contribute to and can be exploited for designing subtype-selective compounds. We describe the roles of secondary binding pockets (SBPs), as well as differences in ligand entry pathways to the orthosteric binding site, in determining selectivity. In addition, using the available crystal structures, we have identified conformational changes in the SBPs that are associated with receptor activation and explore the implications of these changes for the rational development of selective ligands with tailored efficacy. U.S. Government work not protected by U.S. copyright.

Mesh:

Substances:

Year:  2015        PMID: 25527701      PMCID: PMC4279073          DOI: 10.1124/pr.114.009944

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  99 in total

1.  Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study.

Authors:  Isabelle Boileau; Doris Payer; Sylvain Houle; Arian Behzadi; Pablo M Rusjan; Junchao Tong; Diana Wilkins; Peter Selby; Tony P George; Martin Zack; Yoshiaki Furukawa; Tina McCluskey; Alan A Wilson; Stephen J Kish
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

2.  Targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors for developing effective antipsychotics: synthesis, biological characterization, and behavioral studies.

Authors:  Margherita Brindisi; Stefania Butini; Silvia Franceschini; Simone Brogi; Francesco Trotta; Sindu Ros; Alfredo Cagnotto; Mario Salmona; Alice Casagni; Marco Andreassi; Simona Saponara; Beatrice Gorelli; Pia Weikop; Jens D Mikkelsen; Jorgen Scheel-Kruger; Karin Sandager-Nielsen; Ettore Novellino; Giuseppe Campiani; Sandra Gemma
Journal:  J Med Chem       Date:  2014-11-07       Impact factor: 7.446

3.  Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors.

Authors:  A L Gnagey; M Seidenberg; J Ellis
Journal:  Mol Pharmacol       Date:  1999-12       Impact factor: 4.436

4.  Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors.

Authors:  M E Olah; K A Jacobson; G L Stiles
Journal:  J Biol Chem       Date:  1994-10-07       Impact factor: 5.157

Review 5.  Elucidating mechanisms of drug-induced toxicity.

Authors:  Daniel C Liebler; F Peter Guengerich
Journal:  Nat Rev Drug Discov       Date:  2005-05       Impact factor: 84.694

6.  Certain 1,4-disubstituted aromatic piperidines and piperazines with extreme selectivity for the dopamine D4 receptor interact with a common receptor microdomain.

Authors:  Sandhya Kortagere; Peter Gmeiner; Harel Weinstein; John A Schetz
Journal:  Mol Pharmacol       Date:  2004-09-24       Impact factor: 4.436

7.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.

Authors:  Robert Fredriksson; Malin C Lagerström; Lars-Gustav Lundin; Helgi B Schiöth
Journal:  Mol Pharmacol       Date:  2003-06       Impact factor: 4.436

8.  Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody.

Authors:  Aaron M Ring; Aashish Manglik; Andrew C Kruse; Michael D Enos; William I Weis; K Christopher Garcia; Brian K Kobilka
Journal:  Nature       Date:  2013-09-22       Impact factor: 49.962

9.  Activation and allosteric modulation of a muscarinic acetylcholine receptor.

Authors:  Andrew C Kruse; Aaron M Ring; Aashish Manglik; Jianxin Hu; Kelly Hu; Katrin Eitel; Harald Hübner; Els Pardon; Celine Valant; Patrick M Sexton; Arthur Christopoulos; Christian C Felder; Peter Gmeiner; Jan Steyaert; William I Weis; K Christopher Garcia; Jürgen Wess; Brian K Kobilka
Journal:  Nature       Date:  2013-11-20       Impact factor: 49.962

10.  Crystal structures of a stabilized β1-adrenoceptor bound to the biased agonists bucindolol and carvedilol.

Authors:  Tony Warne; Patricia C Edwards; Andrew G W Leslie; Christopher G Tate
Journal:  Structure       Date:  2012-05-09       Impact factor: 5.006

View more
  40 in total

1.  Identification of Positive Allosteric Modulators of the D1 Dopamine Receptor That Act at Diverse Binding Sites.

Authors:  Kathryn D Luderman; Jennie L Conroy; R Benjamin Free; Noel Southall; Marc Ferrer; Marta Sanchez-Soto; Amy E Moritz; Blair K A Willette; Tim J Fyfe; Prashi Jain; Steve Titus; Lisa A Hazelwood; Jeffrey Aubé; J Robert Lane; Kevin J Frankowski; David R Sibley
Journal:  Mol Pharmacol       Date:  2018-08-01       Impact factor: 4.436

2.  The structural determinants of the bitopic binding mode of a negative allosteric modulator of the dopamine D2 receptor.

Authors:  Christopher J Draper-Joyce; Mayako Michino; Ravi Kumar Verma; Carmen Klein Herenbrink; Jeremy Shonberg; Anitha Kopinathan; Peter J Scammells; Ben Capuano; David M Thal; Jonathan A Javitch; Arthur Christopoulos; Lei Shi; J Robert Lane
Journal:  Biochem Pharmacol       Date:  2018-01-09       Impact factor: 5.858

3.  Structural basis for Na(+)-sensitivity in dopamine D2 and D3 receptors.

Authors:  Mayako Michino; R Benjamin Free; Trevor B Doyle; David R Sibley; Lei Shi
Journal:  Chem Commun (Camb)       Date:  2015-05-21       Impact factor: 6.222

4.  Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist.

Authors:  Amy E Moritz; R Benjamin Free; Warren S Weiner; Emmanuel O Akano; Disha Gandhi; Ara Abramyan; Thomas M Keck; Marc Ferrer; Xin Hu; Noel Southall; Joseph Steiner; Jeffrey Aubé; Lei Shi; Kevin J Frankowski; David R Sibley
Journal:  J Med Chem       Date:  2020-05-12       Impact factor: 7.446

5.  VEGAS as a Platform for Facile Directed Evolution in Mammalian Cells.

Authors:  Justin G English; Reid H J Olsen; Katherine Lansu; Michael Patel; Karoline White; Adam S Cockrell; Darshan Singh; Ryan T Strachan; Daniel Wacker; Bryan L Roth
Journal:  Cell       Date:  2019-07-04       Impact factor: 41.582

6.  A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.

Authors:  Marta Sanchez-Soto; Ravi Kumar Verma; Blair K A Willette; Elizabeth C Gonye; Annah M Moore; Amy E Moritz; Comfort A Boateng; Hideaki Yano; R Benjamin Free; Lei Shi; David R Sibley
Journal:  Sci Signal       Date:  2020-02-04       Impact factor: 8.192

7.  Optical Control of Dopamine Receptors Using a Photoswitchable Tethered Inverse Agonist.

Authors:  Prashant C Donthamsetti; Nils Winter; Matthias Schönberger; Joshua Levitz; Cherise Stanley; Jonathan A Javitch; Ehud Y Isacoff; Dirk Trauner
Journal:  J Am Chem Soc       Date:  2017-12-13       Impact factor: 15.419

8.  Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment.

Authors:  Vivek Kumar; Alessandro Bonifazi; Michael P Ellenberger; Thomas M Keck; Elie Pommier; Rana Rais; Barbara S Slusher; Eliot Gardner; Zhi-Bing You; Zheng-Xiong Xi; Amy Hauck Newman
Journal:  J Med Chem       Date:  2016-08-10       Impact factor: 7.446

9.  Computational approaches to detect allosteric pathways in transmembrane molecular machines.

Authors:  Sebastian Stolzenberg; Mayako Michino; Michael V LeVine; Harel Weinstein; Lei Shi
Journal:  Biochim Biophys Acta       Date:  2016-01-22

10.  2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts.

Authors:  Amy Hauck Newman; Francisco O Battiti; Alessandro Bonifazi
Journal:  J Med Chem       Date:  2019-09-24       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.